Thoracic Drainage Devices Market Report 2025

This Thoracic Drainage Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The thoracic drainage devices market size has grown strongly in recent years. It will grow from $0.89 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 8.95%. The growth in the historic period was driven by the increasing prevalence of pulmonary diseases, a rising number of thoracic surgeries, an expanding geriatric population, higher adoption of minimally invasive procedures, and a growing incidence of pneumothorax and pleural effusion.

The thoracic drainage devices market size is expected to see strong growth in the next few years. It will grow to $1.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.58%. In the forecast period, growth is expected to be fueled by rising healthcare expenditures, increased awareness of post-operative care, global improvements in hospital infrastructure, rising demand for portable drainage systems, and the growing use of disposable medical devices. Key trends anticipated during this period include technological advancements in medical devices, innovations in chest drainage systems, the development of smart monitoring systems, improvements in catheter and tubing materials, and the introduction of antimicrobial coatings in drainage devices.

The increasing prevalence of cardiovascular and pulmonary disorders is significantly driving the growth of the thoracic drainage devices market. Cardiovascular and pulmonary disorders, such as coronary heart disease (CHD) and chronic obstructive pulmonary disease (COPD), are rising due to factors such as sedentary lifestyles, poor dietary habits, smoking, and inadequate health monitoring. Thoracic drainage devices play a vital role in managing these conditions by efficiently removing excess fluid, air, or blood from the pleural or thoracic cavity, ensuring proper lung function and cardiovascular health. For instance, the Australian Institute of Health and Welfare reported an increase in CHD-related deaths from 14,100 in 2021 to 14,900 in 2022 and noted that COPD caused 7,691 deaths in 2022. This growing burden of cardiovascular and pulmonary disorders underscores the critical need for effective thoracic drainage solutions, driving market expansion.

The increasing preference for minimally invasive surgeries is expected to drive the growth of the thoracic drainage devices market. These surgeries involve small or no incisions and use advanced tools such as cameras and specialized instruments to minimize tissue damage, shorten recovery times, and reduce scarring compared to traditional open surgeries. The popularity of minimally invasive surgeries is due to their benefits, including faster recovery, lower risk of infection, reduced scarring, and shorter hospital stays. Thoracic drainage devices are essential in these procedures as they effectively manage pleural effusions, air leaks, and fluid buildup, ensuring proper lung expansion and minimizing complications during recovery. For example, in June 2024, the American Society of Plastic Surgeons, a US-based nonprofit organization, reported a 7% growth in minimally invasive procedures in 2023, surpassing the 5% growth rate of traditional surgical procedures. This increasing trend highlights the growing role of thoracic drainage devices in modern surgical practices.

Leading companies in the thoracic drainage devices market are introducing innovative products such as evacuated drainage bottles to enhance efficiency and reduce infection risks during medical procedures. These bottles are medical devices designed to collect and store fluid drained from wounds or surgical sites, typically under vacuum pressure, to promote healing and prevent infection. For instance, in September 2023, Merit Medical Systems Inc., a US-based manufacturer of disposable medical devices, launched the Aspira evacuated drainage bottle. This device is tailored for draining pleural effusions and malignant ascites, allowing patients to self-treat at home with added comfort and control over drainage speed. Additionally, it requires 23% less storage space compared to traditional drainage bottles, offering a more convenient and efficient solution for patients and healthcare providers alike.

Major players in the thoracic drainage devices market are Medtronic plc, Terumo Corporation, Smiths Group plc, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems, Vygon SA, Poly Medicure Ltd., B. Braun Melsungen AG, Medela AG, Utah Medical Products Inc., Angiplast Private Limited, Sterimed Medical Devices Private Limited, Eurosets s.r.l., Redax S.p.a., Sinapi Biomedical (Pty) Ltd., Rocket Medical plc, ATMOS MedizinTechnik GmbH & Co. KG, Argon Medical Devices Inc., Sterimed Medical Devices Pvt. Ltd.

North America was the largest region in the thoracic drainage devices market in 2024. The regions covered in thoracic drainage devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the thoracic drainage devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Thoracic drainage devices are medical instruments designed to remove air, fluid, or blood from the pleural space, preventing complications such as pneumothorax or pleural effusion. These devices typically involve a tube inserted into the chest, connected to a collection system to ensure continuous drainage and facilitate lung re-expansion.

The main types of thoracic drainage devices include digital and traditional systems. Digital thoracic drainage devices incorporate electronic systems to monitor and manage fluid flow, pressure levels, and air leaks in real time, improving patient care and treatment outcomes. The range of products includes thoracic drainage systems, thoracic drainage kits, pleural drainage catheters, and others. These devices are used across various applications, including cardiac surgery, thoracic and pulmonary surgery, and more. End users include hospitals, ambulatory surgical centers, and other healthcare facilities.

The thoracic drainage devices market research report is one of a series of new reports that provides thoracic drainage devices market statistics, including the thoracic drainage devices industry global market size, regional shares, competitors with the thoracic drainage devices market share, detailed thoracic drainage devices market segments, market trends, and opportunities, and any further data you may need to thrive in the thoracic drainage devices industry. This thoracic drainage devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The thoracic drainage devices market consists of sales of chest tubes, closed chest drainage systems, trocar drainage kits, and autotransfusion systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.